Procurement Lot 171

This tender concerns the procurement of medicines listed by the Croatian Health Insurance Fund (HZZO) that have generic parallels. The scope of this procurement covers medicines included in both the Basic and Supplementary lists of the HZZO. These pharmaceuticals are intended for healthcare institutions within the Republic of Croatia. The procurement aims to ensure a consistent and cost-effective supply of essential medications to public health facilities across the country. Key requirements will likely focus on the quality, origin, and availability of the specified generic medicines, ensuring they meet all regulatory standards and the specific needs of Croatian healthcare providers. The tender process will involve evaluating offers based on criteria such as price, delivery timelines, and the ability to supply the full range of listed pharmaceutical products. This initiative is crucial for maintaining the operational capacity of hospitals and clinics and for ensuring patient access to necessary treatments under the national health insurance system. The successful bidder will be responsible for the supply and distribution of these vital medicines, contributing to the overall efficiency and effectiveness of the Croatian healthcare sector.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Croatia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 10,205.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.